LXRX vs MTB · rev $21.8M vs P/E 12, rev $860.0M
Lexicon Pharmaceuticals Inc (LXRX) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
LXRX currently screens at market cap $327.2M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the LXRX and MTB stock pages for the full models.
Not investment advice.